key: cord-1018740-pnc63euh
authors: Stadlmann, Sylvia; Hein-Kuhnt, Robert; Singer, Gad
title: Viropathic multinuclear syncytial giant cells in bronchial fluid from a patient with COVID-19
date: 2020-05-19
journal: J Clin Pathol
DOI: 10.1136/jclinpath-2020-206657
sha: c96531434022c1c4d9bcaf6e3cf63777aa6facad
doc_id: 1018740
cord_uid: pnc63euh

nan

Novel coronavirus (COVID-19) pneumonia has emerged as major global health threat as it continues to spread with increasing number of deaths. COVID-19 is an enveloped, single-stranded RNA coronavirus that is largely transmitted by inhalation of respiratory droplets. Most patients with COVID-19 have mild disease, but approximately 20% develop severe disease with subsequent respiratory symptoms. 1 Early detection of lung involvement by COVID-19 in bronchial fluid may be important for timely therapeutic management. To date, the description of morphological changes in COVID-19 pneumonia is largely based on findings in a small number of autopsies. 1 2 We present a case of a man in his 70s who was transferred to our hospital on 26 March 2020 with a hyperglycaemic crisis and increasing shortness of breath. He was known to have high blood pressure and type 2 diabetes that had been treated with linagliptin. The patient had a history of rectal cancer in 2016, which had been successfully treated by surgery, followed by chemotherapy for 1 month.

At admission, the patient was dehydrated and his blood glucose level was 30 mmol/L (normal range 3.9-5.8 mmol/L). His body temperature was normal. Within a few hours, his oxygen saturation level dropped from 93% to 50% and he was immediately admitted to the isolation ward and intubated. He was given ceftriaxone, clarithromycin and piperacillin/ tazobactam (2×500 mg intravenous). CT from the lung revealed multifokal bilateral ground glass infiltrates at the periphery of the upper lobes with involvement of the right middle lobe suggesting bilateral interstitial pneumonia (figure 1). 3 In addition, there were infiltrates with a positive bronchogram in both lower lobes and a pneumomediastinum, not typical for interstitial pneumonia. There were no pleural effusions. Real time-PCR (RT-PCR) from nasopharyngeal swabs is routinely used for detection of COVID-19. The positive rate of RT-PCR for nasopharyngeal samples was reported to be 63% in early stage of COVID-19, therefore, a significant number of patients may have false negative results. 4 Previous data from SARS-CoV infections showed that RNA levels first peaked in upper respiratory tract but remained higher in lower respiratory tract specimens 3 weeks after onset of illness. 4 The same may be also expected with COVID-19 infections. 5 6 Detection of early cytomorphological changes in the lung from bronchial fluid or BAL may, therefore, help with timely start of COVID-19 surveillance and supportive therapy.

The histopathological features described in COVID-19 infected lungs so far are very similar to those seen in previous SARS-CoV and MERS-CoV infections. 7 So far they were non-specific and included oedema with or without hyaline membranes, pneumocyte hyperplasia, interstitial fibrosis, pulmonary infarction and a predominantly lymphocytic inflammation. 1 Occasional viral inclusion was suspected in single cells by some authors. 1 Remarkably, all authors observed multinucleated giant cells which were not further described.

In MERS-CoV infections, multinucleate syncytial cells, some of them with prominent eosinophilic nucleoli, were also described. 7 It was suspected that multinucleated epithelial cells, pneumocytes and bronchial submucosal gland cells are the main targets in MERS-CoV infection. 7 In our case, the viropathic PostScript multinucleated giant cells were of histiocytic origin. Thus, macrophages in COVID-19 infection may also be targets for COVID-19 beside pneumocytes as was described in pneumonia caused by measles, 8 even though a secondary reactive non-viropathic giant cell response to the viral infection as a cause of the observed changes cannot be excluded. The prominent neutrophilic inflammation in our case may be contributed to the superinfection with MRSA.

In conclusion, the cytopathological detection of virus infected multinuclear macrophages in bronchial fluid or BAL might add substantial early information in COVID-19. 

Autopsy in suspected CoVId-19 cases

CoVId-19 autopsies, oklahoma, UsA

Chest CT findings in coronavirus disease-19 (CoVId-19): relationship to duration of infection

Laboratory diagnosis of emerging human coronavirus infections -the state of the art

Viral load of sArs-CoV-2 in clinical samples

detection of sArs-CoV-2 in different types of clinical specimens

overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses sArs-CoV, Mers-CoV, and 2019-nCoV

Macrophages and dendritic cells are the predominant cells infected in measles in humans

Competing interests none declared.

Provenance and peer review not commissioned; internally peer reviewed.This article is made freely available for use in accordance with BMJ's website terms and conditions for the duration of the covid-19 pandemic or until otherwise determined by BMJ. You may use, download and print the article for any lawful, non-commercial purpose (including text and data mining) provided that all copyright notices and trade marks are retained. re-use. see rights and permissions. published by BMJ.To cite stadlmann s, Hein-Kuhnt r, singer G. J Clin Pathol 2020;73:607-608.